MedPath

Effect of selenium therapy on primary autoimmune hypothyroidism: a randomized clinical trial

Phase 2
Conditions
Primary autoimmune hypothyroidism.
Autoimmune thyroiditis
Registration Number
IRCT201211239014N13
Lead Sponsor
Vice chancellor for Research the Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

(a) age of 18 to 75 years; (b) having primary autoimmune hypothyroidisms; (c) having anti-TPO >200 U/ml
Exclusion criteria: (a) history of Thyroid surgery; (b) history of thyroid cancer; (c) hypothyroidism resulted from hyperthyroidism; (d) history of auto-immune disease and known rheumatologic diseases; (e) pregnancy; (f) renal failure; (g) subclinical hypothyroidism; (h) history of using radioactive iodine, anti thyroid medication, cytotoxic; immunosuppressive, glucocorticoid, amiodaron, lithium, interferon, and chemotherapy

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement of anti-TPO titer. Timepoint: ?After three months. Method of measurement: Through electrochemiluminescence using diasorin set and liaison kit.
Secondary Outcome Measures
NameTimeMethod
TSH. Timepoint: 3 months post intervention. Method of measurement: Laboratory.;T3. Timepoint: 3 months post intervention. Method of measurement: Laboratory.;T4. Timepoint: 3 months post intervention. Method of measurement: Laboratory.;Abdominal pain. Timepoint: 3 months post intervention. Method of measurement: With question.;Hair loss. Timepoint: 3 months post intervention. Method of measurement: With question.;Dizziness. Timepoint: 3 months post intervention. Method of measurement: With question.;Sensation of garlic smell. Timepoint: 3 months post intervention. Method of measurement: With question.;Tremor. Timepoint: 3 months post intervention. Method of measurement: With question.;Sweating. Timepoint: 3 months post intervention. Method of measurement: With question.
© Copyright 2025. All Rights Reserved by MedPath